Anzeige
Mehr »
Dienstag, 30.06.2026 - Börsentäglich über 12.000 News
China kontrolliert Seltene Erden - Brasilien könnte die Antwort sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
309 Leser
Artikel bewerten:
(2)

Corti launches Symphony for Speech-to-Text

Clinical-grade speech models reduce word error rates by up to 93% versus generalist speech models and APIs, powering greater accuracy for the agentic era of healthcare.

COPENHAGEN, Denmark, May 20, 2026 /PRNewswire/ -- Corti, the frontier lab for clinical-grade AI, today launched Symphony for Speech-to-Text: a new generation of clinical-grade speech-to-text models for real-time dictation, conversational transcription, and batch audio file processing. The latest models sharpen the accuracy of today's voice-powered healthcare applications while giving the next generation of clinical agents a more reliable speech layer to reason from.

Highlights from the research include:

  • Up to 93% lower word error rate versus leading speech models tested on English, German, and French medical terminology, achieving 1.4% WER in English compared with 17.7% for OpenAI, 18.1% for ElevenLabs, 17.4% for Whisper, and 18.9% for Parakeet.
  • Clinically usable formatting, reaching 98.3% recall on formatted entities such as dosages, measurements, and dates, compared with 44.3% for the strongest baseline.
  • Dragon Medical One-level clinical dictation performance, achieving 4.6% WER on real-world English medical dictation versus Dragon's 5.7% (improvement of 19%), with higher medical term recall than Dragon (93.5% vs 92.9%).
  • Consistent multilingual gains, with 2.4% WER in German versus 13.0% for the next-best system, and 3.9% WER in French versus 10.6%.

Why it matters

Healthcare's speech recognition options have until now largely split into two categories: general-purpose cloud APIs built for broad-domain transcription and challenged by clinical terminology, or dedicated medical dictation products optimised for clinician dictation but not built as infrastructure for the ambient AI, agents, and real-time clinical support tools now emerging across healthcare. Symphony for Speech-to-Text is Corti's latest answer: a system that produces structured, clinically usable output through a production-grade API designed for a wide range of clinical workflows - helping downstream AI reason over cleaner facts, not just cleaner transcripts.

"Speech has always been one of healthcare's most important inputs," said Andreas Cleve, co-founder and CEO of Corti. "What is changing is what happens after the words are captured. In the agentic era, speech recognition requires more than simply producing a transcript - we need to give AI systems accurate clinical facts to reason from. If a model mishears a medication, dosage, or symptom, every downstream step becomes less reliable. Symphony for Speech-to-Text gives healthcare builders a speech layer accurate enough to thrive in clinical reality."

Early adopters are already building on Symphony for Speech-to-Text in some of the most linguistically demanding clinical environments. Switzerland for example - where care is delivered across multiple languages, often within a single institution - is a stringent proving ground for multilingual medical speech:

"In a clinical conversation, every word matters - a missed medication name, a misheard dosage, or a mistranscribed symptom can change the meaning of an encounter. Symphony's accuracy on clinical terminology gives us the foundation to bring more trusted AI capabilities into clinical workflows with our Voicepoint Xenon platform," said Pierre Corboz, Head of Solutions & Business Development, Voicepoint. "When Corti improves the speech layer, the workflows we build together become sharper, safer, and more useful for clinicians in Switzerland."

Availability

Symphony for Speech-to-Text is generally available today via the Corti API at console.corti.app. Developers can learn more at docs.corti.ai/stt.

Corti has published the full research paper here, with a separate comparison tool supporting more transparent evaluation of medical speech recognition systems.

About Corti

Corti is healthcare's frontier lab for clinical-grade AI. Symphony, its flagship clinical-grade AI model, powers clinical and administrative applications for EHR vendors, virtual care platforms, practice management systems, and life sciences organisations worldwide. Corti serves over 100 million patients annually across health systems including the NHS. The company is headquartered in Copenhagen with offices in New York and London. For more information, visit corti.ai.

Media contact

press@corti.ai
corti.ai/newsroom

Logo - https://mma.prnewswire.com/media/2979272/Corti_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/corti-launches-symphony-for-speech-to-text-302776816.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.